Preferential CTL targeting of Gag is associated with relative viral control in long-term surviving HIV-1 infected former plasma donors from China

Cell Res. 2012 May;22(5):903-14. doi: 10.1038/cr.2012.19. Epub 2012 Jan 31.

Abstract

It is generally believed that CD8(+) cytotoxic T lymphocytes (CTLs) play a critical role in limiting the replication of human immunodeficiency virus type 1 (HIV-1) and in determining the outcome of the infection, and this effect may partly depend on which HIV product is preferentially targeted. To address the correlation between HIV-1-specific CTL responses and virus replication in a cohort of former plasma donors (FPDs), 143 antiretroviral therapy naive FPDs infected with HIV-1 clade B' strains were assessed for HIV-1-specific CTL responses with an IFN-γ Elispot assay at single peptide level by using overlapping peptides (OLPs) covering the whole consensus clade B proteome. By using a Spearman's rank correlation analysis, we found that the proportion of Gag-specific CTL responses among the total virus-specific CTL activity was inversely correlated with viral loads while being positively correlated to CD4 counts, as opposed to Pol- and Env-specific responses that were associated with increased viral loads and decreased CD4 counts. In addition, Vpr-specifc CTL responses showed a similar protective effect with Gag responses, but with a much lower frequency of recognition. Significantly, we also observed an association between HLA-A*30/B*13/Cw*06 haplotype and lower viral loads that was probably due to restricted Gag-specific CTL responses. Thus, our data demonstrate the prominent role of Gag-specific CTL responses in disease control. The advantage of HLA-A*30/B*13/Cw*06 haplotype in viral control may be associated with the contribution of Gag-specific CTL responses in the studied individuals.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Amino Acid Sequence
  • Anti-HIV Agents / therapeutic use
  • Blood Donors
  • CD4 Lymphocyte Count
  • China
  • Cohort Studies
  • Enzyme-Linked Immunospot Assay
  • Female
  • HIV Infections / drug therapy
  • HIV Infections / metabolism*
  • HIV Infections / virology
  • HIV-1 / metabolism*
  • HLA-A Antigens / immunology
  • HLA-B13 Antigen / immunology
  • HLA-C Antigens / immunology
  • Haplotypes
  • Humans
  • Interferon-gamma / metabolism
  • Male
  • Middle Aged
  • Molecular Sequence Data
  • Peptides / chemistry
  • Peptides / metabolism
  • T-Lymphocytes, Cytotoxic / immunology*
  • T-Lymphocytes, Cytotoxic / metabolism
  • Viral Load
  • gag Gene Products, Human Immunodeficiency Virus / antagonists & inhibitors*
  • gag Gene Products, Human Immunodeficiency Virus / metabolism

Substances

  • Anti-HIV Agents
  • HLA-A Antigens
  • HLA-A*30 antigen
  • HLA-B*13:14 antigen
  • HLA-B13 Antigen
  • HLA-C Antigens
  • HLA-C*06 antigen
  • Peptides
  • gag Gene Products, Human Immunodeficiency Virus
  • Interferon-gamma